Aimt stock zacks

Zacks Company Profile for Aimmune Therapeutics, Inc. (AIMT : NSDQ) • Company Description Aimmune Therapeutics, Inc. is a biopharmaceutical company which is engaged in the development of desensitization treatments for peanut and other food allergies.

eVal develop dynamic web-based apps and valuation tools. This page provides a list of peer compay data, include corporation or group name and equity ticker. Leverage: intraday (professional - up to 1:20, retail - up to 1:5), overnight - up to 1:4 Aimmune Therapeutics (Nasdaq:AIMT)‘s stock had its “outperform” rating reissued by research analysts at Wedbush in a research report issued to clients and investors on Wednesday. Aimmune Therapeutics (Nasdaq:AIMT)‘s stock had its “outperform” rating reissued by research analysts at Wedbush in a research report issued to clients and investors on Wednesday. Eldorado Gold (NYSE:EGO) and China Natural Resources (Nasdaq:CHNR) are both small-cap basic materials companies, but which is the superior stock? Eldorado Gold (NYSE:EGO) and China Natural Resources (Nasdaq:CHNR) are both small-cap basic materials companies, but which is the superior stock? Gene-based therapy is one of the next waves of therapeutic innovation to power this decade and far beyond. The FDA approvals regarding the RNA-based medicines of Sarepta Therapeutics (Nasdaq:SRPT) and the gene-therapy, Luxturna, of Spark…

Every week, host and Zacks stock strategist, Tracey Ryniec, will be joined by guests to discuss Aimmune Therapeutics, Inc. (AIMT): Free Stock Analysis Report.

PDC Energy Inc (PDCE) Forecasted to Post Q1 2019 Earnings of $0.61 Per Share Find the latest PayPal Holdings, Inc. (PYPL) stock quote, history, news and other vital information to help you with your stock trading and investing. Find the latest PayPal Holdings, Inc. (PYPL) stock quote, history, news and other vital information to help you with your stock trading and investing. Get the latest PayPal Holdings, Inc. (PYPL) stock news and headlines to help you in your trading and investing decisions. For stock investors, the falling rates environment is now favoring one particular sector: consumer staples. For stock investors, the falling rates environment is now favoring one particular sector: consumer staples.

eVal develop dynamic web-based apps and valuation tools. This page provides a list of peer compay data, include corporation or group name and equity ticker.

Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return.

12/30/2019 · Analysts expect Aimmune Therapeutics Inc (NASDAQ:AIMT) to announce earnings of ($1.04) per share for the current quarter, Zacks reports. Zero analysts have issued estimates for Aimmune Therapeutics’ earnings, with the highest EPS estimate coming in at ($0.92) and the lowest estimate coming in at ($1.11).

Aimmune Therapeutics (Nasdaq:AIMT)‘s stock had its “outperform” rating reissued by research analysts at Wedbush in a research report issued to clients and investors on Wednesday. Eldorado Gold (NYSE:EGO) and China Natural Resources (Nasdaq:CHNR) are both small-cap basic materials companies, but which is the superior stock? Eldorado Gold (NYSE:EGO) and China Natural Resources (Nasdaq:CHNR) are both small-cap basic materials companies, but which is the superior stock? Gene-based therapy is one of the next waves of therapeutic innovation to power this decade and far beyond. The FDA approvals regarding the RNA-based medicines of Sarepta Therapeutics (Nasdaq:SRPT) and the gene-therapy, Luxturna, of Spark… AptarGroup (NYSE: ATR) and Armstrong World Industries (NYSE:AWI) are both mid-cap industrial products companies, but which is the better stock?

Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Visit performance for information about the performance numbers displayed above.

Gene-based therapy is one of the next waves of therapeutic innovation to power this decade and far beyond. The FDA approvals regarding the RNA-based medicines of Sarepta Therapeutics (Nasdaq:SRPT) and the gene-therapy, Luxturna, of Spark… AptarGroup (NYSE: ATR) and Armstrong World Industries (NYSE:AWI) are both mid-cap industrial products companies, but which is the better stock?

Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. AIMT: Aimmune Therapeutics, Inc. EPS. Get the latest EPS stock quote information from Zacks Investment Research. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Visit performance for information about the performance numbers displayed above.